Real-world results of first-line ABVD in patients with classic Hodgkin's lymphoma at a neoplastic disease institute in Lima, Peru.
Objective: To evaluate the clinical characteristics and outcomes of first-line ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) in patients with classical Hodgkin lymphoma treated at a neoplastic disease institute in Lima, Peru. Methods: Retrospective study of previously untreated classical H...
| Publicado en: | Revista Medica Herediana Vol. 36; no. 4; pp. 332 - 345 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Universidad Peruana Cayetano Heredia
Oct-Dec2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |